Another factor contributing to the suppression of insulin secretion in IUGR fetuses is persistent elevations of plasma norepinephrine and epinephrine, which inhibit insulin secretion through α2-adrenergic receptors on β-cells (Jackson et al., 2000). This evidence concerns the gene INS and fetal growth restriction.